Dr. Marco Bortolato's lab at the University of Florida focuses on understanding the complex relationship between alcohol misuse and aggressive behavior. By using animal models, particularly mice with specific genetic traits, the lab investigates how early-life stressors and genetic vulnerabilities can lead to increased aggression and alcohol use. The ultimate goal is to uncover mechanisms that could inform better prevention and treatment strategies for these interrelated issues.

The lab of Dr. Thomas P Burris focuses on developing new treatments for dementia and Alzheimer's disease using synthetic compounds that mimic the effects of exercise. By targeting specific nuclear receptors in the brain, these compounds aim to enhance cognitive function and reduce the characteristic amyloid plaques associated with Alzheimer's. The research is significant as it addresses a growing public health concern with over five million Americans affected by Alzheimer's disease.

Dr. Lina Cui's lab at the University of Florida focuses on developing innovative therapies for age-related diseases, particularly Alzheimer's disease. By using a unique CAR-T cell immunotherapy approach, the lab aims to detect and eliminate senescent cells, which play a significant role in aging and associated disorders. The research could lead to groundbreaking treatments that improve health in the elderly population.

Dr. Jingchuan Guo's lab focuses on improving diabetes care by ensuring equitable access to the latest glucose-lowering medications for socially disadvantaged patients. With a strong emphasis on data analysis and machine learning, the lab aims to identify patient groups who would benefit most from these treatments and develop strategies to enhance their healthcare outcomes. By examining the intersection of health equity and economic evaluation, the lab works to bridge the gap in diabetes care for those at higher risk of complications.

Dr. Md Mahmudul Hasan's lab focuses on addressing opioid use disorder (OUD) through innovative technology. They are developing a machine learning-based tool to predict relapse in patients undergoing treatment. By analyzing electronic health records, the lab aims to create a support system for primary care providers, helping to identify patients at risk for relapse and improve their treatment outcomes. The research combines advanced algorithms with practical clinical applications to enhance patient care in the face of the opioid crisis.

Dr. Steven Michael Smith's research lab at the University of Florida focuses on understanding the mechanisms behind hypertension, particularly resistant hypertension that does not respond to traditional treatments. The lab is investigating the role of gut microbiota and inflammation in blood pressure regulation, as well as how new technologies such as telehealth can improve hypertension management. They aim to discover novel ways to improve blood pressure control in patients through a combined approach of clinical trials and health technology analysis.

Dr. Chengguo Xing's lab explores the use of kava, a traditional beverage known for its relaxing properties, to help smokers quit by alleviating stress and insomnia associated with tobacco abstinence. They conduct clinical trials to investigate how kava affects biological markers related to smoking and stress, ultimately aiming to develop a new dietary supplement that could aid in tobacco cessation. By improving the success rate of quit attempts, their research holds promise for public health by addressing one of the leading causes of preventable disease.

Dr. Jatinder K. Lamba's lab at the University of Florida focuses on understanding pediatric acute myeloid leukemia (AML), a serious and often overlooked childhood cancer. The lab studies the molecular factors that influence prognosis and treatment outcomes in pediatric AML by examining the genomes, proteomes, and metabolomes of leukemic cells. Their research aims to improve risk assessment and establish better therapeutic strategies by integrating various biological data from clinical trials.

Dr. Yanjun Li's lab at the University of Florida focuses on innovative drug discovery using artificial intelligence. The lab develops a unique platform that leverages generative AI to design small molecules based on cell appearance, or morphology, without the need for specific drug targets. This approach could lead to the creation of new medications for diseases that currently lack effective therapies.

Dr. Hendrik Luesch's lab at the University of Florida focuses on discovering new anticancer drugs from marine cyanobacteria, which are special microorganisms that produce unique chemical compounds. By studying these organisms, the team aims to find and develop innovative therapies that can effectively target cancer, particularly drug-resistant forms. Their research combines ecology, genomics, and synthetic chemistry to unlock the therapeutic potential hidden in marine biodiversity.

Dr. Jay P. Mclaughlin's research focuses on understanding how opioids like morphine interact with HIV proteins to affect brain health and behavior. His lab studies the impacts of these substances on brain function and emotional well-being, particularly in people living with both HIV and opioid use disorder. By exploring treatments like dimethylfumarate, which may protect brain function, his work aims to develop better interventions for vulnerable patients.

Dr. Kendall Nettles' lab at the University of Florida studies how hormones like estrogen and cortisol affect cancer and bodily responses to stress. They are working on developing new therapies for breast cancer that can overcome drug resistance and also on improving synthetic glucocorticoids to minimize side effects like muscle atrophy and insulin resistance. By understanding the molecular mechanisms involved, their goal is to create targeted treatments that are more effective and less harmful.

Dr. May Khanna's research lab at the University of Florida focuses on understanding the interactions between TDP-43 and Tau proteins, which are important in Alzheimer's disease and other neurodegenerative disorders. The lab studies how these proteins interact under normal and pathological conditions, and explores potential therapeutic interventions to disrupt harmful interactions. This research could lead to innovative treatments for neurodegenerative diseases.

Dr. Laura Solt's lab at the University of Florida focuses on understanding how certain proteins, known as nuclear receptors, influence the development and behavior of immune cells called TH17 cells, which are important in chronic inflammation and autoimmune diseases. By studying the role of these receptors and their interaction with small molecules, the lab aims to uncover new therapeutic strategies for treating conditions like colitis and Crohn's disease.

Dr. Haesuk Park's lab focuses on improving screening for Hepatitis C virus (HCV) infections in emergency departments, especially among individuals at high risk. They are developing a new screening tool called HepC-EnD that uses advanced machine learning and natural language processing to identify at-risk patients and seamlessly integrate this tool into electronic health records. This research aims to reduce the number of undiagnosed HCV cases and improve patient care by linking individuals to effective treatments and minimizing the transmission risks related to co-infections like HIV.

Dr. Ben Shen's lab at the University of Florida focuses on discovering and developing new natural products and cancer therapies. They study actinobacteria, microorganisms known for producing diverse chemical compounds, to identify and produce novel drugs that can potentially treat various diseases, including cancer. The lab also works on improving antibody-drug conjugates, which are treatments that deliver toxins directly to cancer cells, thereby increasing their effectiveness and reducing side effects.

Dr. Gemma Casadesus's lab focuses on understanding how hormonal changes during menopause affect brain health, particularly in relation to Alzheimer's disease (AD). The lab investigates the role of the LH/CG receptor, which is linked to neuroinflammation and cognitive decline. By exploring how this receptor can influence immune responses in the brain, the research aims to uncover potential therapeutic strategies for women at risk of developing AD as they age.

Dr. Patrick Robert Griffin's research lab focuses on understanding how steroid hormone receptors, particularly the progesterone receptor and the retinoic acid receptor-related orphan receptor gamma (RORy), regulate various physiological processes. The lab uses advanced techniques like Cryo-EM and mass spectrometry to uncover the structural dynamics and activities of these receptors in complex with co-regulatory proteins and DNA. By elucidating the mechanistic details of receptor action, the lab aims to develop targeted therapies for diseases that involve these crucial proteins.

Dr. Mei He's lab at the University of Florida focuses on understanding how aging affects the relationship between the brain and muscles, especially in the context of space travel. By studying extracellular vesicles, which are small particles that carry information between cells, the lab aims to uncover potential therapies that could help prevent neurodegenerative diseases like Alzheimer's and Parkinson's. This research could lead to effective ways to keep astronauts healthier during long missions in microgravity and improve aging-related health on Earth as well.